Patrick Yéni

Medicine · Health Sciences

38h-index15.5kcitations119works0.02yr avg
OpenAlex↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

HIV/AIDS drug development and treatment(76), HIV Research and Treatment(72), HIV/AIDS Research and Interventions(57), HIV-related health complications and treatments(22), Pneumocystis jirovecii pneumonia detection and treatment(13)

Publications116 total

[18F]FDG Positron Emission Tomography for Initial Staging and Healing Assessment at the End of Therapy in Lymph Nodes and Bone Tuberculosis
Frontiers in Medicine·2021· 4 citedOpen Access
Subgroup and Resistance Analyses of Raltegravir for Resistant HIV-1 Infection
UNC Libraries·2021Open Access
Association between first-year virological response to raltegravir and long-term outcomes in treatment-experienced patients with HIV-1 infection
UNC Libraries·2021Open Access
Antiretroviral Treatment of Adult HIV Infection 2008 Recommendations of the International AIDS Society–USA Panel
UNC Libraries·2020· 99 citedOpen Access
Raltegravir with Optimized Background Therapy for Resistant HIV-1 Infection
UNC Libraries·2020· 2 citedOpen Access
Subgroup and Resistance Analyses of Raltegravir for Resistant HIV-1 Infection
UNC Libraries·2020· 2 citedOpen Access
Ordres et désordres dans la sexualité, la conjugalité, la parentalité
Érès eBooks·2019· 1 cited
Metabolic syndrome and endocrine status in HIV-infected transwomen
AIDS·2019· 33 cited
Dolutegravir and lamivudine maintenance therapy in HIV-1 virologically suppressed patients: results of the ANRS 167 trial (LAMIDOL)
Journal of Antimicrobial Chemotherapy·2018· 78 cited
Bio-Composites for Structural Urban Outdoor Applications - a Study of the Impact of Fiber Content on the Durabilité of Flax Fiber-Reinforced Epoxy Composites
HAL (Le Centre pour la Communication Scientifique Directe)·2018
Assessement of Awareness of, Concerns and Attitudes Towards HIV-Related Court-Case Sentences in France in a Representative Sample of People Living with HIV (ANRS VESPA2 Survey)
AIDS and Behavior·2018
Budget impact of antiretroviral therapy in a French clinic cohort
AIDS·2017· 23 cited
Oral Streptococcal Endocarditis, Oral Hygiene Habits, and Recent Dental Procedures: A Case-Control Study
Clinical Infectious Diseases·2017· 47 citedOpen Access
Clinical features and prognostic factors of listeriosis: the MONALISA national prospective cohort study
The Lancet Infectious Diseases·2017· 556 citedOpen Access
Impact of obesity on antiretroviral pharmacokinetics and immuno-virological response in HIV-infected patients: a case–control study
Journal of Antimicrobial Chemotherapy·2016· 25 citedOpen Access
Abacavir has no prothrombotic effect on platelets<i>in vitro</i>
Journal of Antimicrobial Chemotherapy·2016· 11 citedOpen Access
Epidemiological Profile of Newly Diagnosed HIV-Infected Patients in Northern Paris: A Retrospective Study
AIDS Research and Human Retroviruses·2016· 5 cited
Immunity, inflammation and reservoir in patients at an early stage of HIV infection on intermittent ART (ANRS 141 TIPI Trial)
Journal of Antimicrobial Chemotherapy·2015· 4 citedOpen Access
Use of PCR Signal and Therapeutic Drug Monitoring in a Switch Cohort Study to Tenofovir/Emtricitabine/Rilpivirine: A W96 Follow-Up
PLoS ONE·2015· 4 citedOpen Access
Patient-Reported Outcomes After a Switch to a Single-Tablet Regimen of Rilpivirine, Emtricitabine, and Tenofovir DF in HIV-1-Positive, Virologically Suppressed Individuals: Additional Findings From a Randomized, Open-Label, 48-Week Trial
Patient·2015· 15 citedOpen Access
page 1 of 6Next →

Frequent Co-authors

José M. Gatell(14), Scott M. Hammer(11), Donna M. Jacobsen(11), Douglas D. Richman(11), Christine Katlama(11), Robert T. Schooley(10), Melanie Thompson(10), Martin Hirsch(10), Margaret A. Fischl(9), Paul A. Volberding(9), Joan Montaner(8), Mauro Schechter(8), Véronique Joly(7), Michael S. Saag(6), Charles C. J. Carpenter(6), David Katzenstein(6), Stefano Vella(6), Jürgen K. Rockstroh(6), Jean‐Michel Molina(6), Brian Gazzard(5)